Das, D Sharma
Ray, A
Das, A
Song, Y
Tian, Z
Oronsky, B
Richardson, P
Scicinski, J
Chauhan, D
Anderson, K C
Article History
Received: 14 December 2015
Revised: 26 February 2016
Accepted: 11 April 2016
First Online: 27 April 2016
Competing interests
: BO and JS are employees of EpicentRx; KCA is on Advisory board of Celgene, Millenium, Gilead and Sanofi Aventis, and is a Scientific founder of Oncopep and acetylon; DC is consultant to EpicentRx Inc. The remaining authors have no conflict of interest.